NCT05069220View on ClinicalTrials.gov

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions
Neuroendocrine TumorNeuroblastomaPheochromocytomaParaganglioma
Interventions
DRUG

18F-MFBG

Patients with neuroendocrine malignancies receive 2-4 MBq/kg of 18F-MFBG intravenously followed by PET/CT after 60min of injection.

DRUG

68Ga-Dotatate

Patients with malignant PPGL and NB receive intravenously 68Ga-Dotatate followed by PET/CT after 40min of injection.

Trial Locations (1)

100010

RECRUITING

Peking union medical college hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER